person reading

About Kronos Bio Inc - Company Information, Overview, History and Profile

What does Kronos Bio Inc do?

Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.

Kronos Bio Inc Management structure

All Gross Remunerations are in USD
Ms. Barbara Kosacz, J.D.
Chief Operating Officer and General Counsel
-
2024
Gross Remuneration
Year
Dr. Jorge DiMartino, M.D.,PhD
Chief Medical Officer and Executive Vice President, Clinical Development
-
2024
Gross Remuneration
Year
Dr. Christopher Dinsmore, PhD
Chief Scientific Officer
-
2024
Gross Remuneration
Year
Ms. Sandra A. Gardiner
Principal Accounting Officer and Interim Chief Financial Officer
-
2024
Gross Remuneration
Year
Dr. Deborah Knobelman, PhD
Chief Operations Officer, Principal Accounting Officer, Chief Financial Officer, President and Interim Chief Executive Officer
-
2024
Gross Remuneration
Year
Professor Dr. Norbert W. Bischofberger, PhD
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year

Kronos Bio Inc Board of directors

All Gross Remunerations are in USD
Professor Dr. Norbert W. Bischofberger, PhD
Director
-
2024
Gross Remuneration
Year
Dr. Arie S. Belldegrun, F.A.C.S.,M.D.
Chairman of the Board
-
2024
Gross Remuneration
Year
Mr. Joshua A. Kazam
Director
-
2024
Gross Remuneration
Year
Dr. Taiyin Yang, PhD
Independent Director
-
2024
Gross Remuneration
Year
Mr. David M. Tanen
Director
-
2024
Gross Remuneration
Year
Ms. Elena H. Ridloff, C.F.A.
Independent Director
-
2024
Gross Remuneration
Year